SeekPeptides has helped thousands of researchers navigate these exact calculations, and this guide distills that knowledge into one comprehensive reference
10.1186/1742-2094-8-110 J
Vasalou, C., Helmlinger, G
The molecule was developed by Frank Ng's group at Monash University and Metabolic Pharmaceuticals in Australia during the 1990s and 2000s as a potential anti-obesity drug intended to isolate the lipolytic region of hGH without activating the growth hormone receptor or raising IGF-1.nnIn published preclinical work, the fragment has been shown to stimulate lipolysis, suppress lipogenesis, and modulate the beta-3 adrenergic receptor pathway in adipose tissue rather than acting through the classical hGH receptor
KPV is also touted as being good for gut health, tissue repair - including skin damage, like acne, and for regulating the immune system